MediWound Ltd. — Investor Relations & Filings
MediWound Ltd. is a fully integrated biopharmaceutical company that develops, manufactures, and commercializes enzymatic therapeutics for non-surgical tissue repair. The company's core technology focuses on next-generation treatments that selectively remove eschar (non-viable tissue) from severe burns and chronic wounds while preserving healthy tissue. This approach is designed to accelerate healing, improve patient outcomes, and lower overall healthcare costs. Its primary commercial product is a topical biologic for the debridement of severe thermal burns. MediWound maintains a research and development pipeline aimed at expanding its enzymatic platform to address additional unmet medical needs in wound care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - MediWound Ltd. (0001593984) (Filer) | 2026-04-02 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-25 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 33192505 | 6-K - MediWound Ltd. (0001593984) (Filer) | 2026-04-02 | English | ||
| 33039396 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-25 | English | ||
| 32979821 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | ||
| 32979805 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | ||
| 32980027 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | ||
| 30796114 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30796102 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30796091 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 30795971 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 30796127 | 6-K Filing | 2026-01-15 | English | ||
| 12733058 | 6-K | 2026-01-12 | English | ||
|
2025
4 filings
| |||||
| 12733057 | Regulatory Filings 2025 | 2025-12-03 | English | ||
| 12733059 | 6-K | 2025-11-20 | English | ||
| 12733060 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12733061 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
MediWound Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33721/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33721 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33721 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33721 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33721}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MediWound Ltd. (id: 33721)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.